Animal models of dry eye: A critical assessment of opportunities and limitations

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 6, 2004, Pages 1641-1646

  Barabino, Stefano ^a,b   Dana, M Reza ^a,c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; CELL STIMULATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOG; DRY EYE; FEMALE; IMMUNOGENETICS; IMMUNOPATHOGENESIS; KERATOCONJUNCTIVITIS SICCA; LACRIMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SJOEGREN SYNDROME; ANIMAL; DISEASE MODEL; HUMAN; LACRIMAL APPARATUS; LACRIMAL FLUID; MACACA; METABOLISM; RABBIT; RAT; SECRETION;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; DRY EYE SYNDROMES; HUMANS; LACRIMAL APPARATUS; MACACA; MICE; RABBITS; RATS; TEARS;

EID: 3042624009     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-1055     Document Type: Review

References (34)

1. Schaumberg DA, Sullivan DA, Buring JA, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003; 136:318-326.
2. Lemp MA. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221-232.
3. Van Blokland SC, Versnel MA. Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol. 2002;103:111-124.
4. Yang T, Zeng H, Zhang J. MHC class II molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranes. Am J Physiol. 1999;277:C994-C1007.
5. Takahashi M, Ishimaru N, Yanagi K, Haneji N, Saito I, Hayashi Y. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid. Clin Exp Immunol. 1997;109:555-561.
6. Humphreys-Beher MG, Hu Y, Nakagawa Y, Wang PL, Purushotham KR. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome. Adv Exp Med Biol. 1994;350:631-636.
7. Robinson CP, Yamachika S, Bounous DI, et al. A novel NOD-derived murine model of primary Sjögren's syndrome. Arthritis Rheum. 1998;41:150-156.
8. Toda I, Sullivan BD, Rocha EM, Da Silveira LA, Wickham LA, Sullivan DA. Impact of gender on exocrine inflammation in mouse models of Sjögren's syndrome. Exp Eye Res. 1999;69:355-366.
9. Jabs DA, Lee B, Whittum-Hudson J, Prendergast RA. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci. 2001;42: 399-401.
10. Jabs DA, Lee B, Whittum-Hudson JA, Prendergast RA. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci. 2000;41:826-831.
11. 1 hybrid mouse. Curr Eye Res. 1987;6:1237-1248.
12. McCartney-Francis NL, Mizel DE, Frazier-Jessen M, Kulkarni AB, McCarthy JB, Wahl SM. Lacrimal gland inflammation is responsible for ocular pathology in TGF-β1 null mice. Am J Pathol. 1997;151: 1281-1288.
13. McCartney-Francis NL, Mizel DE, Redman RS, et al. Autoimmune Sjögren's-like lesions in salivary glands in TGF-β1-deficient mice are inhibited by adhesion blocking peptides. J Immmunol. 1996; 157:1306-1312.
14. Tsubata R, Tsubata T, Hiai H, et al. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjögren's syndrome. Eur J Immunol. 1996;26:2742-2748.
15. + dendritic cells and expression of Th1 cytokines in the early development of sialodacryoadenitis in the IQI/Jic mouse model of primary Sjögren's syndrome. Autoimmunity. 2003;36:247-254.
16. Hayashi Y, Haneji N, Hamano H, Yanagi K. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Eur J Immunol. 1994;24:2826-2831.
17. Wharen M, Solomin L, Pettersson I, Isenberg D. Autoantibodies repertoire to Ro/Ssa and La/SSB antigen in patients with primary and secondary Sjögren's syndrome. J Autoimmun. 1996;9:537-544.
18. Ulbricht K, Schmidt RE, Witte T. Antibodies against α-fodrin in Sjögren's syndrome. Autoimmun Rev. 2003;2:109-113.
19. Bacman S, Berra A, Sterin-Borda L, Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome. Invest Ophthalmol Vis Sci. 2001;42:321-327.
20. Robinson CP, Brayer J, Yamachika S, et al. Transfer of human serum IgG to nonobese diabetic Igμnull mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci USA. 1998;95:7538-7543.
21. Nguyen KH, Brayer J, Cha S, et al. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum. 2000;43:2297-2306.
22. Zhu Z, Stevenson D, Schechter JE, Mircheff AK, Atkinson R, Trousdale MD. Lacrimal histopathology and ocular surface disease in a rabbit model of autoimmune dacryoadenitis. Cornea. 2003;22:25-32.
23. Liu SH, Prendergast RA, Silverstein AM. Experimental autoimmune dacryoadenitis. I. Lacrimal gland disease in the rat. Invest Ophthalmol Vis Sci. 1987;28:270-275.
24. Maitchouk DY, Beuerman RW, Ohta T, Stern M, Varnell RJ. Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys. Arch Ophthalmol. 2000;118:246-252.
25. Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Ann NY Acad Sci. 2002;966:211-222.
26. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584-589.
27. Burgalassi S, Panichi L, Chetoni P, Saettone MF, Boldrini E. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res. 1999;31:229-235.
28. 1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjögren's syndrome. Clin Immunol Immunopathol. 1998;89:134-140.
29. Fujihara T, Nagano T, Nakamura M, Shirasawa E. Establishment of a rabbit short-term dry eye model. J Ocul Pharmacol Ther. 1995; 11:503-508.
30. Gilbard JP, Rossi SR, Heyda KG. Tear film and ocular surface changes after closure of the meibomian gland orifices in the rabbit. Ophthalmology. 1989;96:1180-1186.
31. Rolando M, Refojo MF. Tear evaporimeter for measuring water evaporation rate from the tear film under controlled conditions in humans. Exp Eye Res. 1983;36:25-33.
32. Dursun D, Wang M, Monroy D, et al. A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 2002;43:632-638.
33. Gao J, Schwalb TA, Addeo JV, Ghosn CR, Stern ME. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical cyclosporin A therapy. Cornea. 1998;17:654-663.
34. Kaswan R, Pappas C Jr, Wall K, Hirsch SG. Survey of canine tear deficiency in veterinary practice. Adv Exp Med Biol. 1998;438:931-939.